YU269379A - Process for obtaining trans-2-subst.-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido(4,3b)indole - Google Patents

Process for obtaining trans-2-subst.-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido(4,3b)indole

Info

Publication number
YU269379A
YU269379A YU02693/79A YU269379A YU269379A YU 269379 A YU269379 A YU 269379A YU 02693/79 A YU02693/79 A YU 02693/79A YU 269379 A YU269379 A YU 269379A YU 269379 A YU269379 A YU 269379A
Authority
YU
Yugoslavia
Prior art keywords
subst
pyrido
hexahydro
indole
aryl
Prior art date
Application number
YU02693/79A
Other languages
English (en)
Inventor
Mc K W Welch
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of YU269379A publication Critical patent/YU269379A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
YU02693/79A 1979-01-23 1979-11-05 Process for obtaining trans-2-subst.-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido(4,3b)indole YU269379A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/005,698 US4224329A (en) 1979-01-23 1979-01-23 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles

Publications (1)

Publication Number Publication Date
YU269379A true YU269379A (en) 1984-04-30

Family

ID=21717248

Family Applications (2)

Application Number Title Priority Date Filing Date
YU02693/79A YU269379A (en) 1979-01-23 1979-11-05 Process for obtaining trans-2-subst.-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido(4,3b)indole
YU02421/83A YU242183A (en) 1979-01-23 1983-12-13 Process for obtaining new lactols

Family Applications After (1)

Application Number Title Priority Date Filing Date
YU02421/83A YU242183A (en) 1979-01-23 1983-12-13 Process for obtaining new lactols

Country Status (34)

Country Link
US (1) US4224329A (de)
JP (4) JPS55100386A (de)
KR (1) KR830001932A (de)
AR (1) AR231291A1 (de)
AT (1) AT376674B (de)
AU (1) AU521986B2 (de)
BE (1) BE881283A (de)
CA (1) CA1144168A (de)
CH (2) CH651040A5 (de)
CS (4) CS221808B2 (de)
DD (2) DD149071A5 (de)
DE (1) DE3002367A1 (de)
DK (1) DK25580A (de)
EG (1) EG14767A (de)
FI (1) FI800179A (de)
FR (3) FR2447379A1 (de)
GB (1) GB2041925B (de)
GR (1) GR73567B (de)
HU (3) HU189174B (de)
IE (1) IE49500B1 (de)
IL (1) IL59189A (de)
IN (1) IN153300B (de)
IT (1) IT1149927B (de)
LU (1) LU82105A1 (de)
NL (1) NL8000385A (de)
NO (2) NO151895C (de)
NZ (3) NZ192175A (de)
PH (4) PH15736A (de)
PL (4) PL126032B1 (de)
PT (1) PT70724A (de)
SE (3) SE441358B (de)
SU (3) SU1168094A3 (de)
YU (2) YU269379A (de)
ZA (1) ZA796374B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431649A (en) * 1979-07-30 1984-02-14 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4431646A (en) * 1979-07-30 1984-02-14 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4432978A (en) * 1979-07-30 1984-02-21 Pfizer Inc. Hexahydro-trans-pyridoindole
US4337250A (en) * 1979-07-30 1982-06-29 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4427679A (en) 1981-01-16 1984-01-24 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4467090A (en) * 1982-09-30 1984-08-21 Pfizer Inc. Compound, 8-fluoro-5-(p-fluorophenyl)-2-[4-(p-fluorophenyl)-4-hydroxybutyryl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
US4477669A (en) * 1982-09-30 1984-10-16 Pfizer Inc. Processes and intermediates useful in the preparation of flutroline
US4451655A (en) * 1982-05-17 1984-05-29 Pfizer Inc. Process for preparing carboline derivatives and compounds used in their preparation
US4698444A (en) * 1982-09-30 1987-10-06 Pfizer Inc. 1,1-bis(p-fluorophenyl)urea
US4568748A (en) * 1982-09-30 1986-02-04 Pfizer Inc. 2-Carbobenzoxy-8-fluoro-5-(p-fluorophenyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
JPS61248502A (ja) * 1985-04-26 1986-11-05 Pioneer Electronic Corp 磁性材料の接合方法
US4672117A (en) * 1985-09-16 1987-06-09 American Home Products Corporation Antipsychotic gamma-carbolines
US4636563A (en) * 1985-09-16 1987-01-13 American Home Products Corporation Antipsychotic γ-carbolines
US4798896A (en) * 1988-01-19 1989-01-17 American Home Products Corporation Antipsychotic gamma-carboline N-oxides
US5075315A (en) * 1990-05-17 1991-12-24 Mcneilab, Inc. Antipsychotic hexahydro-2H-indeno[1,2-c]pyridine derivatives
CA2355716C (en) * 1998-12-21 2010-05-18 Janssen Pharmaceutica N.V. Benzisoxazoles and phenones as .alpha.2-antagonists
RU2329044C1 (ru) * 2006-11-16 2008-07-20 Андрей Александрович Иващенко Лиганды 5-ht6 рецепторов, фармацевтическая композиция, способ ее получения и лекарственное средство

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA551241A (en) * 1958-01-07 S. Abbott Leslie Production of substituted piperidines
US3382250A (en) * 1966-12-07 1968-05-07 Abbott Lab Aroylalkyl derivatives of 1, 2, 3, 4-tetrahydro-5h-pyrido[4, 3b]indoles
US3687961A (en) * 1971-05-03 1972-08-29 Abbott Lab 8-fluoro-2-{8 3-(4-fluorophenylanilinopropyl{9 -gamma-carboline
AR205452A1 (es) * 1973-12-06 1976-05-07 Endo Lab Metodo para preparar nuevos trans-2, 3, 4, 4a, 5, 9b-hexahidro-5-fenil-1h-pirido(4,3-b) indoles
JPS50126699A (de) * 1974-03-20 1975-10-04
AR206812A1 (es) * 1974-04-01 1976-08-23 Pfizer Compuestos intermediarios de azaciclo(3,4-a)indoles 4- y 5-fenil substituidos desprovistos de actividad terapeutica
US4001263A (en) * 1974-04-01 1977-01-04 Pfizer Inc. 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines
SE7702301L (sv) * 1976-04-08 1977-10-09 Endo Lab Trans-hexahydro-pyrido-indoler
SE441448B (sv) * 1977-05-23 1985-10-07 Pfizer Sett att framstella hexahydro-gamma-karbolinforeningar

Also Published As

Publication number Publication date
IT8019373A0 (it) 1980-01-22
DE3002367A1 (de) 1980-07-24
NZ197582A (en) 1984-05-31
JPS5636487A (en) 1981-04-09
GR73567B (de) 1984-03-16
SE8404554D0 (sv) 1984-09-11
FR2447379A1 (fr) 1980-08-22
PH15086A (en) 1982-07-02
NO151895B (no) 1985-03-18
CH651040A5 (fr) 1985-08-30
CS221808B2 (en) 1983-04-29
NZ197581A (en) 1984-05-31
CA1144168A (en) 1983-04-05
LU82105A1 (fr) 1980-08-08
AU5476580A (en) 1980-07-31
IL59189A (en) 1984-01-31
NO794317L (no) 1980-07-24
SU1080746A3 (ru) 1984-03-15
IT1149927B (it) 1986-12-10
IE49500B1 (en) 1985-10-16
SE8404555L (sv) 1984-09-11
EG14767A (en) 1985-12-31
PL126032B1 (en) 1983-07-30
CS221809B2 (en) 1983-04-29
PH15072A (en) 1982-06-03
ZA796374B (en) 1980-11-26
PH15736A (en) 1983-03-18
AT376674B (de) 1984-12-27
US4224329A (en) 1980-09-23
SU1168094A3 (ru) 1985-07-15
AU521986B2 (en) 1982-05-13
PL221248A1 (de) 1980-12-01
HU188201B (en) 1986-03-28
GB2041925A (en) 1980-09-17
FR2453174A1 (fr) 1980-10-31
JPS5636475A (en) 1981-04-09
GB2041925B (en) 1982-10-20
SE8404554L (sv) 1984-09-11
AR231291A1 (es) 1984-10-31
FR2453175B1 (de) 1983-07-29
SE441358B (sv) 1985-09-30
FI800179A (fi) 1980-07-24
FR2453175A1 (fr) 1980-10-31
JPS5740151B2 (de) 1982-08-25
IN153300B (de) 1984-06-30
ATA33380A (de) 1984-05-15
FR2453174B1 (de) 1983-07-29
HU189174B (en) 1986-06-30
JPS5855151B2 (ja) 1983-12-08
CS221807B2 (en) 1983-04-29
HU184712B (en) 1984-10-29
IL59189A0 (en) 1980-05-30
KR830001932A (ko) 1983-05-19
CH648314A5 (fr) 1985-03-15
DD156369A5 (de) 1982-08-18
JPS55100386A (en) 1980-07-31
CS221806B2 (en) 1983-04-29
SE8000329L (sv) 1980-07-24
IE800121L (en) 1980-07-23
NL8000385A (nl) 1980-07-25
SE8404555D0 (sv) 1984-09-11
BE881283A (fr) 1980-07-22
PL126532B1 (en) 1983-08-31
NO151895C (no) 1985-06-26
JPS5636486A (en) 1981-04-09
PL126867B1 (en) 1983-09-30
YU242183A (en) 1984-06-30
NZ192175A (en) 1984-05-31
FR2447379B1 (de) 1983-08-19
NO843041L (no) 1980-07-24
PT70724A (en) 1980-02-01
PH17773A (en) 1984-12-11
SU1333239A3 (ru) 1987-08-23
DK25580A (da) 1980-07-24
DD149071A5 (de) 1981-06-24
PL120774B1 (en) 1982-03-31

Similar Documents

Publication Publication Date Title
YU43116B (en) Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
YU289180A (en) Process for preparing alfa-aryl-1h-1,2,4-triazole-1-ethanols
YU41744B (en) Process for obtaining trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalene amine
YU269379A (en) Process for obtaining trans-2-subst.-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido(4,3b)indole
PT71404A (en) Process for preparing 2,3-dihydro-2,6,7-trisubstituted-5-acylbenzofurans
YU291280A (en) Process for obtaining 6 alpha-fluoro-9 alpha-chloro-prednisolone-17,21-diesters
YU78679A (en) Process for obtaining 1,3-dibenzoyloxy-17 alpha-ethinyl-7 alpha-methyl-1,3,5(10)-estratriene-17 beta-ol
YU42824B (en) Process for obtaining new substituted pyrolidines
YU277682A (en) Process for obtaining new 1,2,4-triazole derivatives
DE3070919D1 (en) Process for preparing 1,3,7-trialkylxanthines
PT72176B (en) Process for preparing 2,3-indoledione derivatives
YU42323B (en) Process for obtaining 3,5-dichloraniline
YU259480A (en) Process for obtaining 1,2,4-oxdiaoline-5-one derivatives
YU298779A (en) Process for preparing 2,6-dialkyl-n-alkoxymethyl-2-chloroacetanilides
YU55679A (en) Process for obtaining 1,2-dioximes
YU284181A (en) Process for obtaining 2,3-dihydro-pyrane
YU298180A (en) Process for preparing 5,10-dihydroimidazo-2,1-quinazoline
YU40759B (en) Process for obtaining 1,2,3-thiadiazole-5-yl-carbamide
YU216479A (en) Process for obtaining 5,6,2-methyl-n-phenyl-1,4-oxathiine-3-carboxamide
YU291182A (en) Process for obtaining 1,2,4-oxadiazine derivatives
IL57850A0 (en) Process for recovering 2,3,5,6-tetrachloro-pyridine
YU57478A (en) Process for obtaining 1,2,3-thiadiazoline-2-ide derivatives
GB2026489B (en) Process for obtaining 1,5-dinitro-anthraquinone
PL116331B2 (en) Process for preparing 2,2,5,9-tetramethyldecadi-4,8-en-1-al
YU307680A (en) Process for obtaining 2,5-dialkyl-phenyl carbamide derivatives